文献速递针灸推拿中医内科

头皮针治疗偏头痛的有效性与安全性:系统综述与Meta分析

Effectiveness and safety of scalp acupuncture for treating migraine: A systematic review and meta-analysis.
PubMed 文献 · Complement Ther Med · 2023-10-05

该系统综述与Meta分析纳入8项随机对照试验共874例偏头痛患者,评估头皮针的有效性与安全性。结果显示,头皮针总有效率高于普通针刺(RR=1.24,95%CI 1.08-1.43,P<0.01),头痛指数显著下降(SMD=-1.27,95%CI -2.06至-0.48,P<0.01),且总有效率高于药物(RR=1.20,95%CI 1.06-1.37,P<0.01),但证据稳健性不足,未报告不良事件。

要点

  • 头皮针总有效率优于普通针刺和药物治疗。
  • 头皮针可显著降低头痛指数。
  • 证据稳健性不足,安全性尚不确定。

核心结论

  • 头皮针治疗偏头痛可能比普通针刺或药物更有效,但支持其有效性的证据不稳健,安全性仍不确定。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、CENTRAL、OASIS、KISS、KoreaMed、NDSL、CiNii、CNKI等数据库自建库至2022年9月,纳入8项RCT共874例患者,无语言限制,两名评价者独立提取数据,采用RoB 2.0评估偏倚风险,RevMan V5.4进行Meta分析。

主要发现

  • 头皮针总有效率高于普通针刺(RR=1.24;95%CI 1.08-1.43;P<0.01)。
  • 头皮针后头痛指数显著下降(SMD=-1.27;95%CI -2.06至-0.48;P<0.01)。
  • 头皮针总有效率高于药物(RR=1.20;95%CI 1.06-1.37;P<0.01)。
  • 未报告不良事件。

关键数值与推荐

  • 纳入8项RCT共874例偏头痛患者,干预为头皮针,对照为普通针刺或药物。
  • 总有效率RR=1.24(95%CI 1.08-1.43;P<0.01)对比普通针刺。
  • 头痛指数SMD=-1.27(95%CI -2.06至-0.48;P<0.01)。
  • 总有效率RR=1.20(95%CI 1.06-1.37;P<0.01)对比药物。

临床怎么用

  • 对于偏头痛患者,可考虑将头皮针作为辅助或替代治疗选项,但需告知患者证据稳健性不足且安全性数据有限。
  • 临床决策时应结合患者具体情况,并优先参考高质量证据。

局限性

  • 支持头皮针有效性的证据不稳健。
  • 安全性尚不确定,未报告不良事件不等同于安全。
  • 纳入研究数量有限(8项RCT),可能存在偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Migraine is a prevalent and disabling neurological disorder affecting a significant proportion of the global population. Although medications are the primary treatment option, their efficacy remains unclear. Thus, alternative therapies such as scalp acupuncture have gained momentum; however, evidence for the effectiveness of scalp acupuncture remains insufficient. Therefore, this review provides evidence regarding the effectiveness and safety of scalp acupuncture for the treatment of migraines. DESIGN: PubMed, EMBASE, CENTRAL, Oriental Medicine Advanced Searching Integrated System, Korean Studies Information Service System, Korean Medical Database, NDSL, Citation Information by NII, and China National Knowledge Infrastructure were searched from their inception to September 2022 to identify randomised controlled trials (RCTs) without language restrictions. Data were collected and analysed independently by two reviewers. The RoB 2.0 tool was used to evaluate the risk of bias, and a meta-analysis was conducted using RevMan software (V5.4). SETTING: Eight RCTs including 874 patients were selected. RESULTS: Scalp acupuncture had a higher total effective rate (relative risk [RR]:1.24; 95% confidence interval [CI]:1.08-1.43; P < 0.01) than that of ordinary acupuncture. The headache index decreased significantly (standardised mean differences [SMD]:-1.27; 95% CI:-2.06 to -0.48; P < 0.01), and the total effective rate was higher (RR:1.20; 95% CI:1.06-1.37; P < 0.01) with scalp acupuncture than with medications. However, evidence supporting the effectiveness of scalp acupuncture was not robust. No adverse events were reported. CONCLUSION: Scalp acupuncture appears to be more effective than other treatments for migraines. However, their safety remains uncertain. PROSPERO REGISTRATION NUMBER: CRD42022348879.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Kim CY, Hwang EH, Heo I, et al. Effectiveness and safety of scalp acupuncture for treating migraine: A systematic review and meta-analysis. Complement Ther Med. 2023. PMID: 37783377. doi:10.1016/j.ctim.2023.102991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。